HomeCompareCIT vs MRK

CIT vs MRK: Dividend Comparison 2026

CIT yields 14.03% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CIT wins by $4462618.90M in total portfolio value
10 years
CIT
CIT
● Live price
14.03%
Share price
$53.50
Annual div
$7.51
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4462618.96M
Annual income
$4,402,331,954,946.55
Full CIT calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CIT vs MRK

📍 CIT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCITMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CIT + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CIT pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CIT
Annual income on $10K today (after 15% tax)
$1,192.38/yr
After 10yr DRIP, annual income (after tax)
$3,741,982,161,704.57/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CIT beats the other by $3,741,982,153,376.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CIT + MRK for your $10,000?

CIT: 50%MRK: 50%
100% MRK50/50100% CIT
Portfolio after 10yr
$2231309.51M
Annual income
$2,201,165,982,372.34/yr
Blended yield
98.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CIT
Analyst Ratings
14
Buy
13
Hold
Consensus: Buy
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CIT buys
0
MRK buys
0
No recent congressional trades found for CIT or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCITMRK
Forward yield14.03%2.76%
Annual dividend / share$7.51$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$4462618.96M$56.8K
Annual income after 10y$4,402,331,954,946.55$9,798.13
Total dividends collected$4458578.66M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: CIT vs MRK ($10,000, DRIP)

YearCIT PortfolioCIT Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$13,506$2,805.61$11,206$366.19+$2.3KCIT
2$21,534$7,082.51$12,650$502.35+$8.9KCIT
3$44,148$21,107.37$14,407$694.19+$29.7KCIT
4$128,126$80,887.02$16,585$967.82+$111.5KCIT
5$575,875$438,780.98$19,342$1,363.89+$556.5KCIT
6$4,302,452$3,686,264.84$22,913$1,947.19+$4.28MCIT
7$56,081,450$51,477,826.78$27,662$2,823.89+$56.05MCIT
8$1,314,215,448$1,254,208,296.50$34,159$4,173.35+$1314.18MCIT
9$56,342,993,216$54,936,782,686.28$43,337$6,308.80+$56342.95MCIT
10$4,462,618,957,687$4,402,331,954,946.55$56,776$9,798.13+$4462618.90MCIT

CIT vs MRK: Complete Analysis 2026

CITStock

CIT Group Inc. operates as the holding company for CIT Bank, N.A. that provides banking and related services to commercial and individual customers. The company operates through Commercial Banking and Consumer Banking segments. The Commercial Banking segment provides a range of commercial lending, leasing, and deposit products; loans comprising revolving lines of credit, term loans, unsecured loans, collateral-backed loans, asset-based loans, commercial real estate loans, and cash flow loans; and ancillary services and products, including cash management, capital markets, and advisory services primarily to small and middle market companies. This segment also offers asset management, factoring, receivable management, and secured financing services; supply chain financing, leasing and equipment financing to small businesses and middle market, and railroads and shippers. The Consumer Banking segment provides checking, savings, money market, and individual retirement accounts; time deposits and certificates of deposit; residential mortgage loans; small business administration loans; payment solutions; and fiduciary services. The company also offers leasing and advisory, and online banking services. It operates through a network of approximately 60 branches located in southern California. CIT Group Inc. was founded in 1908 and is based in New York, New York.

Full CIT Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CIT vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CIT vs SCHDCIT vs JEPICIT vs OCIT vs KOCIT vs MAINCIT vs JNJCIT vs ABBVCIT vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.